SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 17th, 2017 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus • Nevada
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 13, 2017, by and between GUIDED THERAPEUTICS, INC., a Delaware corporation, with headquarters located at 5835 Peachtree Corners East, Suite D, Norcross, GA 30092 (the “Company”), and AUCTUS FUND, LLC, a Delaware limited liability company, with its address at 101 Arch Street, 20th Floor, Boston, MA 02110 (the “Buyer”).
COMMON STOCK PURCHASE WARRANT GUIDED THERAPEUTICS, INC.Common Stock Purchase Warrant • February 17th, 2017 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus • Nevada
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the $170,000.00 convertible promissory note to the Holder (as defined below) of even date) (the “Note”), Auctus Fund, LLC, a Delaware limited liability company (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Guided Therapeutics, Inc., a Delaware corporation (the “Company”), up to 200,000 shares of Common Stock (as defined below) (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated February 13, 2017, by and among the Comp
